HK Stock Market Move | HEARTCARE-B (06609) rose nearly 9% in late trading; its A-share IPO process is steadily advancing and is expected to enhance the liquidity of the company's shares.

HEARTCARE-B (06609) rose nearly 9% in late trading. As of press time, it was up 8.36% at HK$61.6, with a turnover of HK$11.4164 million. On the news front, HeartCare Medical plans to submit an application to the Shanghai Stock Exchange in the second half of 2026 for an initial public offering of A-shares and listing on the STAR Market, aiming to raise approximately RMB 500 million. The proceeds will be mainly used for brain science medical device construction projects, vascular interventional medical device R&D and production projects, and R&D and registration projects. China Securities Co.,Ltd. stated that the company is steadily advancing its A-share IPO process and is expected to further enhance capital market liquidity through the A-share IPO in the future. It will also leverage the power of the capital market to further accelerate the company's global commercialization layout through both organic and inorganic means. At the same time, the company will continue to advance share buybacks, cash dividends, and other initiatives based on its operating conditions and regulatory requirements.